Evidence map›Paper›PMID 37516799›Full record

ReviewInternational journal of impotence research2024

Exploring representation of underrepresented minority men in a restorative therapy clinical trial for erectile dysfunction: addressing barriers and promoting inclusion.

Braian R Ledesma, Jamie Thomas, Armin Ghomeshi, Russell G Saltzman, Abraham Almatari, Joshua White, Maria Camila Suarez Arbelaez, Ranjith Ramasamy

Abstract readReview
PubMed Publisher
In one paragraph

Review in International journal of impotence research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Braian R LedesmaDesai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, FL, USA.ORCID http://orcid.org/0000-0003-1091-5493
Jamie ThomasDesai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
Armin GhomeshiHerbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.
Russell G SaltzmanDesai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, FL, USA.ORCID http://orcid.org/0000-0003-0494-3869
Abraham AlmatariUniversity of Tennessee Health Science Center, College of Medicine, Memphis, TN, USA.
Joshua WhiteDesai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
Maria Camila Suarez ArbelaezDesai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
Ranjith RamasamyDesai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, FL, USA. ramasamy@miami.edu.
University of Miami · USFlorida International University · USUniversity of Tennessee Health Science Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This retrospective descriptive analysis explores underrepresented minority men in our clinical trial for restorative therapy for erectile dysfunction and to identify strategies to promote diversity and inclusion in the study population. Demographic data were collected from all participants and the prevalence in our population was compared to the source population. The proportion of individuals taking part in our clinical trial was compared to the overall disease population using the participation to prevalence ratio. Among the 61 participants enrolled in the Platelet-Rich Plasma for Erectile Dysfunction trial, 72.1% were Hispanic compared to 39.9% in the national source population. There were 27.9% non-Hispanic participants, and 41.2% non-Hispanic men in the local South Florida population. The racial composition of our study shows 80.3% of PRP participants identify as White, 16.4% as Black, and 3.4% as Asian. In the national source population, 61.8% of patients were White, 27.5% are black, and 1.5% are Asian. Through the implementation of strategies such as having Hispanic team members on the clinical trial staff and providing education and outreach materials both in Spanish and English, we were able to overcome barriers to participation in Hispanic men and potentially improve health outcomes for underrepresented minority men with erectile dysfunction.

Indexed as

Erectile DysfunctionHispanic or LatinoAdultAgedFloridaHumansMaleMiddle AgedMinority GroupsPatient SelectionRetrospective Studies

Identifiers

PMID37516799
OpenAlexW4385381849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.